Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Modern Rheumatology|January 4, 2012
Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in JapanMasaaki Mori, Syuji Takei, Tomoyuki Imagawa, et al.
Modern Rheumatology|April 12, 2011
Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trialsMasaaki Mori, Syuji Takei, Tomoyuki Imagawa, et al.
Modern Rheumatology|December 5, 2015
Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritisMasayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, et al.
Modern Rheumatology|December 7, 2016
Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in JapanTsuneyo Mimori, Masayoshi Harigai, Tatsuya Atsumi, et al.
Modern Rheumatology|August 22, 2018
Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018Nami Okamoto, Shumpei Yokota, Syuji Takei, et al.
Modern Rheumatology|September 16, 2018
Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillanceMasayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, et al.
Modern Rheumatology|December 9, 2017
Characteristics and outcome of intractable vasculitis syndrome in children: Nation-wide survey in JapanNaoko Nakano, Masaaki Mori, Hiroaki Umebayashi, et al.
Modern Rheumatology|April 4, 2018
Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance studyTsuneyo Mimori, Masayoshi Harigai, Tatsuya Atsumi, et al.
Pediatric Rheumatology Online Journal|May 2, 2019
Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label studyRyoki Hara, Hiroaki Umebayashi, Syuji Takei, et al.
Arthritis Research & Therapy|April 10, 2014
Ultrasonographic assessment reveals detailed distribution of synovial inflammation in Blau syndromeKei Ikeda, Naotomo Kambe, Syuji Takei, et al.
Pageof 9